Presage Biosciences known for its expertise in evaluating oncology drugs within human tumors has initiated Phase dosing with PBA an antibody from Pure Biologics that targets ROR

Kashiv BioSciences LLC has completed patient enrollment for its Phase III clinical trial of ADL a biosimilar candidate to XOLAIR This pivotal trial is designed to assess how ADL compares to XOLAIR

Dren Bio Inc a private clinicalstage biopharmaceutical company has announced a strategic collaboration with Novartis Pharma AG a subsidiary of Novartis AG This partnership aims to advance the discovery

Charles River Laboratories International Inc and Autobahn Labs a virtual accelerator for academic biotech supported by Samsara BioCapital have unveiled a strategic collaboration Charles River

Oisn Biotechnologies a private biotech company focused on combating agerelated diseases has announced the initial close of its million Series A funding round AbbVie Ventures led this first tranche

ViroCell Biologics a contract development and manufacturing organization specializing in GMP viral vector production has secured a fiveyear Master Services Agreement MSA with a major US

Tonix Pharmaceuticals Holding Corp a fullyintegrated biopharmaceutical company with marketed products and a pipeline of development candidates today announced that the US Food and Drug Administration has granted Fast Track

Pfizer Inc today announced that the European Commission has granted conditional marketing authorization for DURVEQTIX a gene therapy for the treatment of severe and moderately severe hemophilia B in adult patients

Sandoz the global leader in generic and biosimilar medicines announces the launch of Pyzchiva ustekinumab across Europe starting today Pyzchiva developed and registered by Samsung Bioepis is the first ustekinumab biosimilar

Hoth Therapeutics Inc a patientfocused biopharmaceutical company today announced it has signed an agreement with LTS Therapy Systems LLC to develop and manufacture the HTALZ oral film prototype